{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:36:43Z","timestamp":1791578203737,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jchf.2025.102822","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:28:27Z","timestamp":1762633707000},"page":"102822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evolutionary History of the Comorbidity-Driven Coronary Microvascular Endothelial Inflammation Hypothesis and Its Metamorphosis to the Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction"],"prefix":"10.1016","volume":"14","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jchf.2025.102822_bib1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1532-5415.1982.tb01983.x","article-title":"Left ventricular function in hospitalized geriatric patients","volume":"30","author":"Luchi","year":"1982","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jchf.2025.102822_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","article-title":"Hypertensive hypertrophic cardiomyopathy of the elderly","volume":"312","author":"Topol","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","article-title":"Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms","volume":"11","author":"Maurer","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000053947.82595.03","article-title":"Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?","volume":"107","author":"Burkhoff","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cardfail.2011.03.010","article-title":"The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction","volume":"17","author":"Abramov","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00392-011-0305-4","article-title":"Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction","volume":"100","author":"Edelmann","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jchf.2025.102822_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003989","article-title":"Biomarker profiles in heart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102822_bib11","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jchf.2025.102822_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102638","article-title":"What causes inflammation in heart failure and preserved ejection fraction? Potential role of eicosanoid adipokines","volume":"13","author":"Packer","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ehf2.14626","article-title":"Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis","volume":"11","author":"D\u2019Amario","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.122.059280","article-title":"Characteristics of heart failure with preserved ejection fraction across the range of left ventricular ejection fraction","volume":"14","author":"Rosch","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","article-title":"Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy","volume":"47","author":"Olivotto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/157016108785909779","article-title":"The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure","volume":"6","author":"Hoenig","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jchf.2025.102822_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/cvr\/cvy038","article-title":"Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening","volume":"114","author":"Sorop","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2025.102822_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jchf.2025.102822_bib23","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2025.102822_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003509","article-title":"Prevalence and importance of coronary microvascular dysfunction in patients with heart failure and reduced or mildly reduced ejection fraction","volume":"12","author":"Nordberg Backelin","year":"2025","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2025.102822_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejheart.2007.06.003","article-title":"Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function","volume":"9","author":"Balmain","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"10.1016\/j.jchf.2025.102822_bib26","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.3390\/jcm13226841","article-title":"Moderately increased left ventricular filling pressure suggesting early stage of heart failure with preserved ejection fraction in patients with invasively assessed coronary microvascular dysfunction","volume":"13","author":"Arkowski","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jchf.2025.102822_bib27","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/ehf2.14929","article-title":"Coronary microvascular dysfunction and left heart filling pressures in patients with type 2 diabetes","volume":"11","author":"Wolsk","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jchf.2025.102822_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yjmcc.2019.10.005","article-title":"Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model","volume":"137","author":"Waddingham","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"Van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cvr\/cvs353","article-title":"Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction","volume":"97","author":"Hamdani","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2025.102822_bib35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCULATIONAHA.112.124909","article-title":"Heart failure: a PKGarious balancing act","volume":"126","author":"Kass","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.792798","article-title":"Cyclic GMP and PKG signaling in heart failure","volume":"13","author":"Numata","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jchf.2025.102822_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCRESAHA.111.300105","article-title":"Crucial role for Ca2(+)\/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation","volume":"112","author":"Hamdani","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.102822_bib39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.yjmcc.2009.01.004","article-title":"Titin-based mechanical signalling in normal and failing myocardium","volume":"46","author":"Kr\u00fcger","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","article-title":"Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium","volume":"104","author":"Borb\u00e9ly","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.102822_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCRESAHA.108.184408","article-title":"Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs","volume":"104","author":"Kr\u00fcger","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.102822_bib42","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib43","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102822_bib44","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102822_bib45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/jama.2020.16641","article-title":"Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction: the CAPACITY HFpEF randomized clinical trial","volume":"324","author":"Udelson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102822_bib46","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102822_bib47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited","volume":"128","author":"Paulus","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.102822_bib48","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib49","doi-asserted-by":"crossref","first-page":"H604","DOI":"10.1152\/ajpheart.00552.2020","article-title":"SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload","volume":"320","author":"Riley","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2025.102822_bib50","doi-asserted-by":"crossref","first-page":"H331","DOI":"10.1152\/ajpheart.00274.2020","article-title":"Pressure overload generates a cardiac-specific profile of inflammatory mediators","volume":"319","author":"O\u2019Brien","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2025.102822_bib51","doi-asserted-by":"crossref","first-page":"H92","DOI":"10.1152\/ajpheart.00719.2017","article-title":"Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis","volume":"315","author":"McDonald","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2025.102822_bib52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.33549\/physiolres.934183","article-title":"Chronic peripheral ghrelin injection exerts antifibrotic effects by increasing growth differentiation factor 15 in rat hearts with myocardial fibrosis induced by isoproterenol","volume":"69","author":"Ren","year":"2020","journal-title":"Physiol Res"},{"issue":"8","key":"10.1016\/j.jchf.2025.102822_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114573","article-title":"Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy","volume":"43","author":"Chan","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jchf.2025.102822_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib55","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/cvr\/cvac179","article-title":"Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions","volume":"118","author":"Peters","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2025.102822_bib56","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib57","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"De Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib58","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102822_bib59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.0000000000000321","article-title":"Daprodustat and heart failure in CKD","volume":"35","author":"Cunningham","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.102822_bib60","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jchf.2025.102822_bib61","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","article-title":"Central adiposity or hypertension: which drives heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2025.102822_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib63","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/labinvest.2012.97","article-title":"Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice","volume":"92","author":"Lai","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.jchf.2025.102822_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107711","article-title":"Tocilizumab does not ameliorate inflammation-induced left ventricular dysfunction in a collagen-induced arthritis rat model","volume":"75","author":"Manilall","year":"2025","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jchf.2025.102822_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.41095","article-title":"Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial","volume":"72","author":"Giles","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jchf.2025.102822_bib66","series-title":"Package insert\/prescribing information","year":"2018"},{"key":"10.1016\/j.jchf.2025.102822_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib68","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: the COLICA trial","volume":"45","author":"Pascual-Figal","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102822_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133045","article-title":"Colchicine for secondary prevention in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"425","author":"Shaikh","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib70","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cardfail.2023.04.003","article-title":"Myeloperoxidase inhibition in heart failure with preserved or mildly reduced ejection fraction: SATELLITE trial results","volume":"30","author":"Lam","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib72","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10741-025-10498-y","article-title":"Myeloperoxidase inhibition in the landscape of anti-inflammatory therapies for heart failure with preserved ejection fraction: the ENDEAVOR trial","volume":"30","author":"Kittipibul","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2025.102822_bib73","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/jamacardio.2024.2435","article-title":"Verinurad plus allopurinol for heart failure with preserved ejection fraction: the AMETHYST randomized clinical trial","volume":"9","author":"Kitzman","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jacc.2020.05.072","article-title":"Effect of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFpEF","volume":"76","author":"Cunningham","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2025.102822_bib75","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2025.102822_bib76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib77","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib78","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib79","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ejhf.1167","article-title":"Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction","volume":"20","author":"Packer","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib80","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jchf.2025.102822_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010618","article-title":"Obesity-related biomarkers are associated with exercise intolerance and HFpEF","volume":"16","author":"Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijcard.2016.11.194","article-title":"HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin","volume":"228","author":"Fax\u00e9n","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12872-017-0509-2","article-title":"Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromso Study","volume":"17","author":"Norvik","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2025.102822_bib84","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","article-title":"Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction","volume":"7","author":"Tanaka","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib85","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11010-022-04562-6","article-title":"The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism","volume":"478","author":"Mao","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jchf.2025.102822_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12265-019-09913-1","article-title":"Effects of adiponectin on diastolic function in mice underwent transverse aorta constriction","volume":"13","author":"Han","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jchf.2025.102822_bib87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2015.03.007","article-title":"Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1","volume":"84","author":"Li","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib88","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41598-017-06997-0","article-title":"Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome","volume":"7","author":"Fr\u00fchbeck","year":"2017","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.jchf.2025.102822_bib89","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2025.07.052","article-title":"Is type 2 diabetes a modifiable risk factor for the evolution and progression of heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jchf.2025.102822_bib90","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jacc.2025.08.086","article-title":"Chronic kidney disease in patients with heart failure with a preserved ejection fraction: the underlying role of visceral adiposity","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2025.102822_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002711","article-title":"Adiposity, fat-free mass and incident heart failure in 500 000 individuals","volume":"11","author":"Oguntade","year":"2024","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-023-02836-4","article-title":"Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain","volume":"21","author":"Choy","year":"2023","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.jchf.2025.102822_bib93","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030818","article-title":"Clinical characteristics and rhythm outcomes in patients with atrial myopathy after successful catheter ablation of atrial fibrillation","volume":"13","author":"Kim","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102822_bib94","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","article-title":"Extracellular vesicles from epicardial fat facilitate atrial fibrillation","volume":"143","author":"Shaihov-Teper","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib95","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cjco.2025.03.024","article-title":"Prediction of atrial fibrillation using radiomic features of left atrial epicardial adipose tissue on noncontrast cardiac computed tomography","volume":"7","author":"Cohen-Dor","year":"2025","journal-title":"CJC Open"},{"issue":"3","key":"10.1016\/j.jchf.2025.102822_bib96","article-title":"Relationship between epicardial adipose tissue and atrial fibrillation in heart failure with preserved ejection fraction","volume":"17","author":"Yucel","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jchf.2025.102822_bib97","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/dc08-1596","article-title":"Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals","volume":"32","author":"Lieb","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2025.102822_bib98","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/14728222.2015.1019468","article-title":"Association between plasma leptin and adiponectin levels and diastolic function in the general population","volume":"19","author":"Fontes-Carvalho","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jchf.2025.102822_bib99","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-014-0126-7","article-title":"Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population","volume":"13","author":"Fuseya","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14518-2","article-title":"Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchf.2025.102822_bib101","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/ehf2.14064","article-title":"Resistin and risks of incident heart failure subtypes and cardiac fibrosis: the Multi-Ethnic Study of Atherosclerosis","volume":"9","author":"Cai","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib102","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cardfail.2021.04.001","article-title":"Associations of angiopoietins with heart failure incidence and severity","volume":"27","author":"Peplinski","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib103","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"De Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102822_bib104","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2025.03.530","article-title":"Disentangling the impact of adiposity from insulin resistance in heart failure with preserved ejection fraction","volume":"85","author":"Reddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jchf.2025.102822_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102656","article-title":"Adipoexosomal microRNAs as adipose tissue-derived messengers in heart failure and a preserved ejection fraction","volume":"13","author":"Packer","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102822_bib106","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102822_bib107","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/apha.12739","article-title":"Adipocytokine, progranulin, augments acetylcholine-induced nitric oxide-mediated relaxation through the increases of cGMP production in rat isolated mesenteric artery","volume":"219","author":"Kazama","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jchf.2025.102822_bib108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20130286","article-title":"Chemerin reduces vascular nitric oxide\/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?","volume":"127","author":"Neves","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib109","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-023-02887-7","article-title":"Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism","volume":"21","author":"Zhang","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.jchf.2025.102822_bib110","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1161\/ATVBAHA.123.319476","article-title":"Galectin-3 mediates vascular dysfunction in obesity by regulating NADPH oxidase 1","volume":"43","author":"Padgett","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jchf.2025.102822_bib111","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10741-012-9349-4","article-title":"Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure","volume":"18","author":"Van Berendoncks","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2025.102822_bib112","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/dmrr.778","article-title":"Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise","volume":"23","author":"Vu","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.jchf.2025.102822_bib113","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006040","article-title":"Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation","volume":"11","author":"Kondo","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jchf.2025.102822_bib114","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/COPD.S510828","article-title":"Association between visceral adipose tissue and chronic respiratory diseases: a two-sample multivariable Mendelian randomization study in European population","volume":"20","author":"Huang","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jchf.2025.102822_bib115","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jchf.2025.102822_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.03.042","article-title":"Obesity and risk of kidney outcomes in heart failure with preserved ejection fraction: a participant-level pooled analysis of 4 contemporary trials","volume":"13","author":"Lassen","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2025.102822_bib117","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12872-021-02080-9","article-title":"Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cardiovasc Disord"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925007528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925007528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:33:23Z","timestamp":1770060803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925007528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213177925007528"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102822","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolutionary History of the Comorbidity-Driven Coronary Microvascular Endothelial Inflammation Hypothesis and Its Metamorphosis to the Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102822"}}